Outcomes research can play a key role in the drug development process. At DRG Abacus, we have a dedicated Clinical Outcomes Assessment (COA) team whose members have extensive methodological and commercial experience.
The COA team have expertise in the development and validation of new and existing patient-reported outcomes (PROs) and other COAs used to assess important patient outcomes including symptoms, functioning, health-related quality of life (HRQoL), and treatment experience.
Our specialists are supported by a multidisciplinary team of medical writers, health economists, systematic reviewers and strategic advisors. Together, these experts provide integrated health economics and outcomes research (HEOR) and market access solutions across the product life-cycle.
We are part of Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd.
DRG offers best-in-class, high-value data, analytics and insights products and services to the healthcare industry, delivered by more than 1,000 employees across 17 offices in North America, Europe and Asia.Our Company